Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof
CA 2313381 A1 · Owner: Genetics Institute, Llc · Inventors: Murray, Beth L.; Celeste, Anthony J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Purified BMP-17 and BMP-18 proteins and processes for producing them are disclosed. DNA molecules encoding the BMP-17 and BMP-18 proteins are also disclosed. The proteins may be used in the treatment of bone cartilage, other , connective tissue defects and disorders including tendon, ligament and , meniscus in wound healing and related tissue repair as well as for treatment , of disorders and defects to tissues which include epidermis nerve, muscle, including cardiac muscle and other tissues and wounds, and organs such as liver, lung, epithelium, brain, spleen cardiac, pancreas and kidney tissue. , The proteins may also be useful for the induction of growth and/or differentiation of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 17, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 17, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 17, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.